Streamline Health(US:STRM) Globenewswire·2025-06-16 20:05Core Insights - Streamline Health Solutions reported a total revenue increase of approximately 12% to $4.8 million for the first quarter of fiscal 2025 compared to $4.3 million in the same period of fiscal 2024, driven by new SaaS contracts despite some client non-renewals [2][4] - SaaS revenue grew by 23% to $3.4 million, representing 70% of total revenue in Q1 2025, up from 63% in Q1 2024 [3] - The company experienced a reduced net loss of $1.6 million in Q1 2025, an improvement from a net loss of $2.7 million in Q1 2024, attributed to increased revenue and cost savings from strategic restructuring [4][5] - Streamline Health Solutions entered into a definitive merger agreement with MDaudit for an all-cash transaction valued at approximately $37.4 million, with a share price premium of 138% over the last trading day prior to the announcement [6] Financial Performance - Total revenue for Q1 2025 was $4.8 million, a 12% increase from $4.3 million in Q1 2024 [2] - SaaS revenue for Q1 2025 was $3.4 million, a 23% increase from $2.7 million in Q1 2024, making up 70% of total revenue [3] - Adjusted EBITDA improved to $0.2 million in Q1 2025 from a loss of $0.7 million in Q1 2024, reflecting the company's focus on SaaS revenue growth and cost savings [5][18] Balance Sheet and Cash Flow - As of April 30, 2025, cash and cash equivalents were $1.4 million, down from $2.2 million as of January 31, 2025 [4][16] - Total assets increased to $35.8 million as of April 30, 2025, compared to $35.6 million as of January 31, 2025 [16] - Total liabilities rose to $24.8 million as of April 30, 2025, from $23.3 million as of January 31, 2025 [16] Merger Agreement - The merger with MDaudit is expected to close in the third quarter of calendar year 2025, with MDaudit acquiring all outstanding shares of Streamline stock for $5.34 per share [6]